Q3 2022 Holdings
Filed 2022-11-14 | 44 holdings | $63.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $15.5M | 550,000 | 24.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $13.4M | 300,000 | 20.9% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $9.8M | 95,000 | 15.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $9.0M | 600,000 | 14.0% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $6.6M | 525,000 | 10.3% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $5.6M | 435,000 | 8.7% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $2.8M | 200,000 | 4.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $1.0M | 3,750 | 1.6% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $39.7K | 500,000 | 0.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $18.8K | 275,000 | 0.0% |
| Relmada Therapeutics Inc(RLMD)Put | COM | 75955J402 | $18.5K | 500,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $18.2K | 725,000 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $15.7K | 425,000 | 0.0% |
| Dice Therapeutics IncCall | COM | 23345J104 | $14.2K | 700,000 | 0.0% |
| Amylyx Pharmaceuticals Inc(AMLX)Put | COM | 03237H101 | $14.1K | 500,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $12.2K | 175,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $12.2K | 110,000 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $11.6K | 2,000,000 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $11.0K | 535,000 | 0.0% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $10.5K | 390,000 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $8.6K | 360,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $8.3K | 463,700 | 0.0% |
| Seagen Inc(SGENUSD)Call | COM | 81181C104 | $6.8K | 50,000 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $6.7K | 30,000 | 0.0% |
| Axsome Therapeutics Inc(AXSM)Call | COM | 05464T104 | $6.7K | 150,000 | 0.0% |
| Tricida Inc(1T7)Call | COM | 89610F101 | $5.2K | 500,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $5.2K | 500,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR)Call | CL A | 75615P103 | $5.0K | 200,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $4.8K | 200,000 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $4.6K | 75,000 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $4.5K | 525,000 | 0.0% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $4.5K | 500,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $4.3K | 65,000 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $2.8K | 60,000 | 0.0% |
| Aerovate Therapeutics Inc | COM | 008064107 | $2.5K | 150,000 | 0.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $2.3K | 300,000 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $2.2K | 90,000 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $2.1K | 200,000 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $2.1K | 120,000 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $1.7K | 100,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $1.6K | 25,000 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $1.6K | 65,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR)Call | COM | 46583P102 | $1.1K | 61,300 | 0.0% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $526 | 1,000,000 | 0.0% |